Table 2.

Indications for LMWH treatment

Disease	Prophylaxis (n=13 cases)	Therapeutic (n=40 cases)
History of DVT and/or PE	4 (30.8%)	10 (25%)
History of DVT and/or PE and thrombophilia	1 (7.7%)	6 (15%)
Current DVT and/or PE	0	14 (35%)
Current DVT and thrombophilia	0	2 (5%)
Thrombophilia, no VTE	6 (30.8%)	2 (5%)
Mitral valve replacement	0	3 (7.5%)
History of cerebral vein and sinus thrombosis	0	2 (5%)
History of sinus thrombosis and thrombophilia	1 (7.7%)	1 (2.5%)
Maternal disease (Nephrotic syndrome)	1 (7.7%)	0